COMT Val158met Moderation of Dopaminergic Drug Effects on Cognitive Function: a Critical Review

Overview

Journal Pharmacogenomics J

Specialties Genetics
Molecular Biology
Pharmacology

Date 2016 Jun 1

PMID 27241058

Citations 51

Authors

J P Schacht

Affiliations

Soon will be listed here.

Abstract

The relationship between dopamine (DA) tone in the prefrontal cortex (PFC) and PFC-dependent cognitive functions (for example, working memory, selective attention, executive function) may be described by an inverted-U-shaped function, in which both excessively high and low DA is associated with impairment. In the PFC, the COMT val158met single nucleotide polymorphism (rs4680) confers differences in catechol-O-methyltransferase (COMT) efficacy and DA tone, and individuals homozygous for the val allele display significantly reduced cortical DA. Many studies have investigated whether val158met genotype moderates the effects of dopaminergic drugs on PFC-dependent cognitive functions. A review of 25 such studies suggests evidence for this pharmacogenetic effect is mixed for stimulants and COMT inhibitors, which have greater effects on D1 receptors, and strong for antipsychotics, which have greater effects on D2 receptors. Overall, COMT val158met genotype represents an enticing target for identifying individuals who are more likely to respond positively to dopaminergic drugs.

Citing Articles

Dopaminergic Epistases in Schizophrenia.

Bosun A, Albu-Kalinovic R, Neda-Stepan O, Bosun I, Farcas S, Enatescu V Brain Sci. 2024; 14(11).

PMID: 39595853 PMC: 11592377. DOI: 10.3390/brainsci14111089.

Dopamine in Sports: A Narrative Review on the Genetic and Epigenetic Factors Shaping Personality and Athletic Performance.

Huminska-Lisowska K Int J Mol Sci. 2024; 25(21).

PMID: 39519153 PMC: 11546834. DOI: 10.3390/ijms252111602.

Neural indices of heritable impulsivity: Impact of the COMT Val158Met polymorphism on frontal beta power during early motor preparation.

Happer J, Beaton L, Wagner L, Hodgkinson C, Goldman D, Marinkovic K Biol Psychol. 2024; 191:108826.

PMID: 38862067 PMC: 11853962. DOI: 10.1016/j.biopsycho.2024.108826.

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments.

Hernandez M, Cullell N, Cendros M, Serra-Llovich A, Arranz M Pharmaceutics. 2024; 16(2).

PMID: 38399298 PMC: 10893329. DOI: 10.3390/pharmaceutics16020244.

The influence of the COMT Val158Met polymorphism on prefrontal TDCS effects on aggression.

Weidler C, Hofhansel L, Regenbogen C, Muller D, Clemens B, Montag C Sci Rep. 2024; 14(1):3437.

PMID: 38341445 PMC: 10858895. DOI: 10.1038/s41598-024-53930-3.

References

Arnsten A . Catecholamine regulation of the prefrontal cortex. J Psychopharmacol. 1997; 11(2):151-62. DOI: 10.1177/026988119701100208. View

Ryan S . Regression to the truth: replication of association in pharmacogenetic studies. Pharmacogenomics. 2003; 4(2):201-7. DOI: 10.1517/phgs.4.2.201.22631. View

Ghahremani D, Lee B, Robertson C, Tabibnia G, Morgan A, De Shetler N . Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci. 2012; 32(21):7316-24. PMC: 3517177. DOI: 10.1523/JNEUROSCI.4284-11.2012. View

Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O . Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 1997; 385(6617):634-6. DOI: 10.1038/385634a0. View

Chudasama Y, Robbins T . Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology. 2004; 29(9):1628-36. DOI: 10.1038/sj.npp.1300490. View

Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J . Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(8):1431-5. DOI: 10.1002/ajmg.b.30704. View

Barnett J, Scoriels L, Munafo M . Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry. 2008; 64(2):137-44. DOI: 10.1016/j.biopsych.2008.01.005. View

Mueller E, Makeig S, Stemmler G, Hennig J, Wacker J . Dopamine effects on human error processing depend on catechol-O-methyltransferase VAL158MET genotype. J Neurosci. 2011; 31(44):15818-25. PMC: 6623004. DOI: 10.1523/JNEUROSCI.2103-11.2011. View

Mehta M, Manes F, Magnolfi G, Sahakian B, Robbins T . Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology (Berl). 2004; 176(3-4):331-42. DOI: 10.1007/s00213-004-1899-2. View

10.

Apud J, Weinberger D . Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs. 2007; 21(7):535-57. DOI: 10.2165/00023210-200721070-00002. View

11.

Hakkarainen J, Jalkanen A, Kaariainen T, Keski-Rahkonen P, Venalainen T, Hokkanen J . Comparison of in vitro cell models in predicting in vivo brain entry of drugs. Int J Pharm. 2010; 402(1-2):27-36. DOI: 10.1016/j.ijpharm.2010.09.016. View

12.

Mattay V, Goldberg T, Fera F, Hariri A, Tessitore A, Egan M . Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A. 2003; 100(10):6186-91. PMC: 156347. DOI: 10.1073/pnas.0931309100. View

13.

Sawaguchi T, Goldman-Rakic P . D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 1991; 251(4996):947-50. DOI: 10.1126/science.1825731. View

14.

Floresco S . Prefrontal dopamine and behavioral flexibility: shifting from an "inverted-U" toward a family of functions. Front Neurosci. 2013; 7:62. PMC: 3630325. DOI: 10.3389/fnins.2013.00062. View

15.

Farrell S, Tunbridge E, Braeutigam S, Harrison P . COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition. Biol Psychiatry. 2012; 71(6):538-44. PMC: 3314969. DOI: 10.1016/j.biopsych.2011.12.023. View

16.

Goldman-Rakic P, Muly 3rd E, Williams G . D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev. 2000; 31(2-3):295-301. DOI: 10.1016/s0165-0173(99)00045-4. View

17.

Wardle M, Hart A, Palmer A, de Wit H . Does COMT genotype influence the effects of d-amphetamine on executive functioning?. Genes Brain Behav. 2012; 12(1):13-20. PMC: 3553317. DOI: 10.1111/gbb.12012. View

18.

Giakoumaki S, Roussos P, Bitsios P . Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology. 2008; 33(13):3058-68. DOI: 10.1038/npp.2008.82. View

19.

Grace A . Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 1991; 41(1):1-24. DOI: 10.1016/0306-4522(91)90196-u. View

20.

Mata I, Arranz M, Staddon S, Lopez-Ilundain J, Tabares-Seisdedos R, Murray R . The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis. Psychiatr Genet. 2006; 16(5):213-6. DOI: 10.1097/01.ypg.0000218626.26622.a2. View